SAS vs Python in Pharma: What Actually Gets You Hired

Every week on forums and LinkedIn, career-switchers ask whether learning Python will help them bypass SAS to break into clinical trials. The short answer is no. While biostatistics groups increasingly adopt Python and R for exploratory analyses, internal dashboards, and data quality checks, the core regulatory submission pipeline at major sponsors and CROs remains anchored in validated SAS environments.

More importantly, focusing entirely on programming syntax misses the real filter in hiring. When a Lead Statistical Programmer reviews candidates, syntax fluency is assumed. The real filter is whether you understand clinical trial data structures and regulatory accountability.

The Same Deliverable in Two Languages #

Consider a standard safety deliverable: Table 14.3.1.1, summarizing treatment-emergent adverse events by treatment arm from an ADaM ADAE dataset.

Here is the query in SAS:

proc sql;
    select trt01a,
           count(distinct usubjid) as n_subj
    from adae
    where trtemfl = 'Y'
    group by trt01a;
quit;

Here is the exact same logic in Python using pandas:

import pandas as pd

adae = pd.read_sas("adae.xpt", format="xport")

(adae[adae.trtemfl == "Y"]
    .groupby("trt01a")["usubjid"]
    .nunique())

Both snippets read the submission dataset, filter for treatment-emergent events, and produce the subject counts in a fraction of a second. The mechanics of typing this code are straightforward in both tools.

The Logic Neither Language Teaches You #

Writing those lines correctly requires domain rules that have nothing to do with Python or SAS syntax. In an actual trial, getting any of these details wrong creates an audit finding:

1. Subject incidence versus event frequency: A subject with four occurrences of headache must count once in an incidence table. Using a basic row count (count(*) or len()) overcounts patients and corrupts safety percentages.
2. Planned versus actual treatment: If four patients randomized to active drug accidentally received placebo kits at the site, grouping by planned treatment (TRT01P) instead of actual treatment (TRT01A) produces invalid safety groupings.
3. Derivation traceability: The treatment-emergent flag (TRTEMFL) must be derived strictly according to the protocol rules specified in the SAP, cross-referencing adverse event start dates against first dose dates.
4. Independent double-programming: Before this table reaches the clinical study report, a validation programmer independently re-programs it from the raw or SDTM data to ensure identical results down to the decimal point.

A Realistic Preparation Sequence #

If your goal is to land a clinical programming role, sequencing your study matters more than picking sides in a language debate:

1. Master core SAS DATA step and PROC SQL: Learn how the Program Data Vector processes records, how formats work in memory, and how to write clean, warning-free logs.
2. Learn CDISC foundational standards: Focus on SDTM domains (DM, AE, LB) and ADaM data structures (ADSL, ADAE, ADLB), with strict attention to variable naming and traceability.
3. Practice building from mock shells: Take a sample Statistical Analysis Plan and write derivation specifications for primary endpoints.
4. Add Python as a complementary skill: Use libraries like pandas, pyreadstat, and saspy for automated data reconciliation and file comparison.

Learning syntax in either language takes a couple of weeks. Understanding how to derive baseline flags, interpret CDISC implementation guides, and independently double-program a dataset to zero discrepancy is what actually gets you hired.